Singapore markets close in 2 hours 29 minutes
  • Straits Times Index

    3,212.17
    -13.18 (-0.41%)
     
  • Nikkei

    26,402.84
    -508.36 (-1.89%)
     
  • Hang Seng

    20,155.17
    -489.11 (-2.37%)
     
  • FTSE 100

    7,438.09
    -80.26 (-1.07%)
     
  • BTC-USD

    29,207.13
    -736.66 (-2.46%)
     
  • CMC Crypto 200

    651.13
    -19.55 (-2.92%)
     
  • S&P 500

    3,923.68
    -165.17 (-4.04%)
     
  • Dow

    31,490.07
    -1,164.52 (-3.57%)
     
  • Nasdaq

    11,418.15
    -566.37 (-4.73%)
     
  • Gold

    1,811.90
    -4.00 (-0.22%)
     
  • Crude Oil

    110.29
    +0.70 (+0.64%)
     
  • 10-Yr Bond

    2.8860
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,551.02
    -3.89 (-0.25%)
     
  • Jakarta Composite Index

    6,817.00
    +23.58 (+0.35%)
     
  • PSE Index

    6,699.69
    -27.91 (-0.41%)
     

Sabra Health Care REIT, Inc. to Participate in the Stifel 2022 Seniors Housing and Healthcare Real Estate Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

IRVINE, Calif., January 13, 2022--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and Lukas Hartwich, the company’s Senior Vice President of Finance, will participate in the Stifel 2022 Seniors Housing and Healthcare Real Estate Conference virtually on January 27, 2022.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220113005867/en/

Contacts

Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting